Announced Mon, 10 Aug · 14:22 IST
IOL CP Q1 FY27 results: Revenue up 37% YoY to Rs 756 Cr, PAT jumps 90%
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹167.50
prior close
₹169.09
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7-0.2-1.3-1.9-2.2-5.6-0.9-0.6-3.8-6.0————
Up moveDown movePending
AI summary
IOL Chemicals and Pharmaceuticals posted strong Q1 FY27 results. Revenue from operations grew about 37 percent YoY to Rs 756.26 Cr from Rs 551.69 Cr. Profit after tax jumped around 90 percent YoY to Rs 64.48 Cr from Rs 33.96 Cr. Pharma segment revenue rose 42.5 percent to Rs 469.49 Cr while Chemicals grew nearly 30 percent to Rs 364.96 Cr. EBITDA margin expanded to about 14.6 percent from 12.4 percent YoY. EPS stood at Rs 2.20 vs Rs 1.16. Auditors issued an unmodified opinion.
Likely market impact
Strong topline and bottomline growth with margin expansion. Both Pharma and Chemical segments grew sharply YoY. Positive for shareholders.